Skip to main content
Caplight Logo









Until Labs

Until Labs

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.untillabs.com/

Last Round

Series A

Sep 22, 2025

Total Funding Raised

$48M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Until Labs is a biotechnology company that develops perfusion hardware, cryoprotective agents, and rewarming infrastructure for organ-scale reversible cryopreservation.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

cryopreservationorgan preservationvitrificationbiotechnologyorgan transplantcryobiologymedical hardwareperfusion systemscryoprotectantrewarming technologybiopreservationorgan logisticstransplant technologycryonicsdeep freeze

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Until Labs Comparables

Compare Until Labs with similar companies based on industry and business-model similarity.

Until Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
X-Therma
84%
Bridge to Life
75%
21st Century Medicine, Inc.
74%

Until Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 22, 2025
SeedJun 6, 2024

Key People

Founding team and executive leadership

Laura Deming

CEO, Co-founder

Founding Team

Until Labs Investors

Notable investors and investment history

Until Labs investors
InvestorRounds
Field VenturesSeries A
Field VenturesSeries A
Founders FundSeries A
Lux CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2025

    $58M round led by Founders Fund.

  • Jun 6, 2024

    $48M raised in Seed round.

Until Labs Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Until Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Until Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range40
Year Founded2024
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?